* Ekso Bionics Holdings Inc EKSO.OQ EKSO.O is expected
to show
a rise in quarterly revenue when it reports results on October
28 for the period ending September 30 2024
* The San Rafael California California-based company is
expected
to report a 20.5% increase in revenue to $5.551 million from
$4.61 million a year ago, according to the mean estimate from 2
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Ekso Bionics Holdings
Inc is
for a loss of 10 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Ekso
Bionics
Holdings Inc is 6.25, above its last closing price of $1.03.
This summary was machine generated October 22 at 14:13 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)